20/06/2026
And they are off!
mRNA vax soon to trial because "The travel-related outbreak and potential for sequential transmission events underscore the urgency for vaccine development" and "Importantly, our demonstration of single-dose protection, with dose-sparing and early immune response potential, is compelling evidence for accelerating advancement towards clinical trials and licensure."
The May, 2026, Andes virus outbreak on the Dutch cruise ship (MV Hondius) that departed from Argentina,1 where the lethal virus was first described,2 represents a transmission context unprecedented in the known epidemiology of the virus. The Andes virus is the only member of the Hantaviridae family....
